10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q3 2014

Filing Information

Form Type	10-Q
Accession Number	`0001144204-14-068781`
Period End Date	20140930
Filing Date	20141114
Fiscal Year	2014
Fiscal Period	Q3
XBRL Instance	bpth-20140930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 48 Cash Flow Statement 40

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$534.05K	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$14.64M	USD	Point-in-time
Cash	`Cash`	$3.55M	USD	Point-in-time
Cash	`Cash`	$4.10M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$51.36K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$96.56K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$64.12K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$194.18K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$14.93M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.67M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Fixed assets	`AssetsNoncurrent`	$66.12K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	89.24M	shares	Point-in-time
Fixed assets	`AssetsNoncurrent`	-	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	84.24M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	84.24M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	89.24M	shares	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.09M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.21M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.29M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.41M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$5.08M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$16.28M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$88.51K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$76.11K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$77.59K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$66.74K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$52.05K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$67.05K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$100.00K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$50.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$294.90K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$283.16K	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$294.90K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$283.16K	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 89,237,872 and 84,237,872 shares issued and outstanding as of 9/30/14 and 12/31/13, respectively	`CommonStockValue`	$84.24K	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 89,237,872 and 84,237,872 shares issued and outstanding as of 9/30/14 and 12/31/13, respectively	`CommonStockValue`	$89.24K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$34.23M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$20.10M	USD	Point-in-time
Accumulated deficit	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$18.32M	USD	Point-in-time
Accumulated deficit	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$15.40M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$16.00M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.78M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$5.08M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$16.28M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	3 Qtrs
Revenue	`Revenues`	-	USD	3 Qtrs
Revenue	`Revenues`	-	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$40.16K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$120.47K	USD	3 Qtrs
Amortization	`AdjustmentForAmortization`	$40.16K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$120.47K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$424.52K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.05M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.13M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$568.58K	USD	1 Quarter
General & administrative	`GeneralAndAdministrativeExpense`	$1.85M	USD	3 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$810.15K	USD	1 Quarter
General & administrative	`GeneralAndAdministrativeExpense`	$1.29M	USD	3 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$713.35K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$1.39M	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$1.15M	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$2.94M	USD	3 Qtrs
Total operating expense	`OperatingExpenses`	$2.48M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-1.39M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.15M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-2.94M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-2.48M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$17.35K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$837.00	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.49K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$5.71K	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$295.00	USD	3 Qtrs
Other expense	`OtherNonoperatingExpense`	$661.00	USD	3 Qtrs
Other expense	`OtherNonoperatingExpense`	$316.00	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$14.00	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$5.70K	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$17.06K	USD	3 Qtrs
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$1.83K	USD	3 Qtrs
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$521.00	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-2.48M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-1.39M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-2.92M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-1.15M	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	3 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	3 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	68.07M	shares	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.24M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	75.38M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.24M	shares	3 Qtrs

Cash Flow Statement 40 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.48M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.39M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.92M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.15M	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$40.16K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$120.47K	USD	3 Qtrs
Amortization	`AdjustmentForAmortization`	$40.16K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$120.47K	USD	3 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$635.60K	USD	3 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$327.12K	USD	3 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$-46.70K	USD	3 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$45.20K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$7.14K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$130.06K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-11.74K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-155.49K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.84M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.66M	USD	3 Qtrs
Purchase of fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	3 Qtrs
Purchase of fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$66.12K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-66.12K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	-	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$5.40M	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$13.81M	USD	3 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$5.40M	USD	3 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$13.81M	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$3.57M	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$11.08M	USD	3 Qtrs
Cash, beginning of period	`Cash`	$534.05K	USD	Point-in-time
Cash, beginning of period	`Cash`	$14.64M	USD	Point-in-time
Cash, beginning of period	`Cash`	$3.55M	USD	Point-in-time
Cash, beginning of period	`Cash`	$4.10M	USD	Point-in-time
Cash, end of period	`Cash`	$534.05K	USD	Point-in-time
Cash, end of period	`Cash`	$14.64M	USD	Point-in-time
Cash, end of period	`Cash`	$3.55M	USD	Point-in-time
Cash, end of period	`Cash`	$4.10M	USD	Point-in-time
Interest	`InterestPaid`	-	USD	3 Qtrs
Interest	`InterestPaid`	-	USD	3 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.